Description

History / Background

SS-31, also known as Elamipretide, is a synthetic tetrapeptide developed to improve mitochondrial function by targeting mitochondrial cardiolipin—a key phospholipid essential for maintaining mitochondrial structure and energy production. By selectively binding to cardiolipin, SS-31 helps stabilize the inner mitochondrial membrane, enhance ATP production, and reduce oxidative stress. Originally derived from a segment of human cytochrome-c, SS-31 has been extensively researched for its potential role in treating diseases related to mitochondrial dysfunction. This includes cardiovascular diseases, neurodegenerative disorders, metabolic conditions, and age-related declines in mitochondrial efficiency. Elamipretide has undergone multiple clinical trials evaluating its safety, tolerability, and therapeutic potential, and it has received orphan drug designations for certain rare mitochondrial disorders.

Research For:

Potential benefits of SS-31 include:

1. Mitochondrial Protection
   SS-31 shields mitochondria from structural and functional damage, helping maintain optimal energy production and cellular performance.

2. Enhanced ATP Production
   By improving mitochondrial efficiency, SS-31 supports greater ATP output, which may translate into increased cellular energy.

3. Reduced Oxidative Stress
   SS-31 helps decrease the formation of reactive oxygen species (ROS), lowering inflammation and protecting cells from oxidative damage.

4. Cardioprotective Effects
   Research suggests SS-31 may help protect heart tissue, particularly in conditions such as heart failure and ischemia-reperfusion injury.

5. Neuroprotective Properties
   Due to its mitochondrial-supportive action, SS-31 has shown potential in conditions like Alzheimer’s and Parkinson’s disease, where mitochondrial dysfunction plays a key role.

Important Considerations

• Regulatory Status
  SS-31 (Elamipretide) has not yet gained wide regulatory approval. While it has orphan drug designation for certain mitochondrial conditions, its long-term safety and efficacy remain under investigation.

• Source & Purity
  Many SS-31 products available online are sold as research chemicals and are not regulated. Purity and formulation can vary significantly, increasing safety risks.

• Potential Side Effects
  Reported side effects in early trials are generally mild and may include:

  • Injection-site irritation

  • Temporary redness or discomfort
    Broader safety data is still being collected.

• Medical Guidance
  Anyone considering SS-31 for wellness, anti-aging, or performance purposes should consult a healthcare professional, given its experimental status and limited long-term data.